The Evolving Role of Imaging in Identification and Management of Prostate Cancer

摘要

Prostate cancer is the most common cancer in men. The disease is newly diagnosed in more than 230,000 men and responsible for more than 30,000 deaths each year in the United States.1 Recent trends from the National Cancer Institute Surveillance, Epidemiology, and End Results program demonstrate that approximately 90% of prostate cancer patients, regardless of race, were diagnosed with localized prostate cancer between 1995 and 2000.1 However, one of the great challenges of this malignancy is the determination of the extent of disease, which remains a critical issue for the selection of appropriate therapy.